Abstract: Lichens (a composite organism) are known for their secondary metabolites and have several properties as photoprotection, allelopathy, antioxidant, antimicrobial, and antiviral. In this study, based on alarming situation of prevalence and developing resistance in dermatophytes, the new biological source in the form of lichens was screened for their antidermatophytic potential. 
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PUBLIC INTEREST STATEMENT
The developing resistance against first line clinical drug in pathogens is an evolutionary process for survival. Due to developing resistance in pathogens, we have to search for new drugs or compounds or herbals for our backup. We humans always rely on nature for our needs and mostly nature provides us solution in the form of any biological source. In present study, one of the less explored biological sources i.e. lichens were investigated. Lichens are a composite organism (composed of a fungus and a photobiont (algae and cyanobacteria or both)), slow growing in nature and acts as a pollution indicator. Lichens are used since long back in human civilization for their several benefits viz. antimicrobial, perfume, edible and many more. The present study enhances the existing knowledge and provides new leads for the cure of prevalent disease dermatophytosis (fungal infection of skin).
Introduction
Filamentous keratinophilic fungi causing cutaneous mycoses are called dermatophytes and are classified into three genera, Trichophyton, Microsporum, and Epidermophyton (Peres, Maranhão, Rossi, & Martinez-Rossi, 2010) . So far, about 30 species of dermatophytes have been identified among human pathogens (White, Oliver, Graser, & Henn, 2008) . Dermatophytes are cosmopolitan in distribution. A study involving 16 European countries showed that 35-40% of the analyzed individuals had infection of the foot (tinea pedis) caused by dermatophytes (Burzykowski et al., 2003) . A study involving children's in US revealed that between 22 and 55% were having hair scalp infection of dermatophytes (Abdel-Rahman, Simon, Wright, Ndjountche, & Gaedigk, 2006) . Although, the prevalence of drug resistance in dermatophytes is rare but resistance cases have been reported for griseofulvin, terbinafine, and fluconazole (Orozco et al., 1998; Peres et al., 2010; Smith et al., 1986; Stephenson, 1997; Wingfield, Fernandez-Obregon, Wignall, & Greer, 2004) . In present study, based on the alarming situation documented in aforementioned literatures, the less explored biological source in the form of lichens was screened for their antidermatophytic potential. Lichen (a composite organism) thallus is a consortium of mycobiont and photobiont in a mutualistic relationship (Hawksworth, 2000) . Apart from photobiont and mycobiont the lichen thallus is comprised of several other lichenicolous fungi, endophytic fungi, and bacteria (Grube & Berg, 2009) . Lichens are known for their secondary metabolites which are quite unique to them and have several properties as photoprotection, allelopathy, antioxidant, antimicrobial, and antiviral (Molnar & Farkas, 2010) .
Results and discussion

Percent yield
Percent yield obtained for Bulbothrix setschwanensis was highest i.e. 5.5%; Parmotrema nilgherrense was 4.5%; Parmotrema reticulatum was 4.45%; Myelochroa aurulenta was 3.75%; and least for Ramalina conduplicans i.e. 3.5%.
Antidermatophytic activity of lichens
The antidermatophytic activity of various lichen extracts were tabulated in Table 1 ) (Carrillo-Munoz, Tur-Tur, Cardenes, Estivill, & Giusiano, 2011) . The difference in the MIC values is due to the size of inoculum. In the previous study, the initial inoculum size was 4.7 × 10 3 to 1.5 × 10 4 CFU/ml whereas in present study the inoculum size was ca 0.5 × 10 6 CFU/ml. Sertaconazole nitrate a highly active chemical drug having low fingistatic and fungicidal activities but it cause inflammation and itching to the patients (Liebel, Lyte, Garay, Babad, & Southall, 2006) . Lichen extracts possess antidermatophytic activity but the most potent lichen extract was of M. aurulenta which had MIC values against all three pathogens present in this study. B. setschwanensis exhibited activity against all three pathogens but only 50% inhibition was achieved. R. conduplicans showed activity against Trichophyton spp. whereas; P. nilgherrense exhibited activity against Microsporum sp. and was least effective amongst all; P. reticulatum exhibited activity against Microsporum canis and T. mentagrophytes. 
Statistical analysis
The significance level in the mean difference of control and treated columns in independent samples t-test are: Sertaconazole were 0. 
(T. rubrum).
Secondary metabolites reported from M. aurulenta are zeorin, atranorin, secalonic acid A, and leucotylic acid (Singh & Sinha, 2010) . Among aforementioned compounds atranorin and zeorin exhibits weak antifungal properties. Atranorin doesn't exhibit any activity against filamentous fungi but was found active against Candida albicans and Candida glabrata with MIC values of 500 μg for each (Turk, Yilmaz, Tay, Turk, & Kivanc, 2006; Yilmaz, Turk, Tay, & Kivanc, 2004) . On the other hand, zeorin exhibited MIC values above 3 mg ml −1 against filamentous fungi (Marijana, Branislav, & Slobodan, 2010) . Both the aforementioned compound either possess no or very weak antifungal activity. Thus, secalonic acid A and leucotylic acid need to be tested against dermatophytes or it might be possible that there was a synergy in between aforementioned compounds is the future leads of this present investigation. 
Material and methods
Collection of lichens
Lichen thalli were collected from Chakrata district, Uttarakhand, India and identified with the help of relevant key (Awasthi, 2007) . The voucher specimens were submitted in Central Regional Circle, Allahabad, Botanical Survey of India viz. B. setschwanensis (BSA-8763), M. aurulenta (BSA-8761), P. nilgherrense (BSA-8757), P. reticulatum (BSA-8762), and R. conduplicans (BSA-8759).
Preparation of lichen extracts
Two grams of lichen thalli were taken for cold extraction in 50% acetone (50 ml) (the solvent is a mixture of polar and non-polar solvent so that maximum amount of secondary as well as primary metabolites can diffuse into the solvent). Subsequently, the extracts were filtered by Whatman No. 1 filter paper and crude extract was obtained using rotary evaporator and weighed. The weight of crude extracts obtained were 0.11 g, 0.075 g, 0.09 g, 0.089 g, and 0.07 g for B. setschwanensis, M. aurulenta, P. nilgherrense, P. reticulatum, and R. conduplicans, respectively. Percent yield of crude extracts were calculated according to below mentioned formula:
Stock solutions (50 mg/ml) of crude extracts were prepared in dimethyl sulphoxide (DMSO) for antifungal susceptibility test.
Test pathogens and inocula preparation
Fungal cultures of M. canis (MTCC No. 3270), T. mentagrophytes (MTCC No. 7687), and T. rubrum (MTCC No. 296) were procured from Microbial Type Culture Collection and Gene Bank (MTCC), Chandigarh, India, which were subcultured on SDA medium under laminar flow cabinet (Laminar flow ultra clean air unit, Micro-Filt, India). Inocula were prepared in saline media and then adjusted to a 0.5 McFarland standard, corresponding to ca 0.5 × 10 6 CFU/ml and transmittance of inoculum prepared was 70-72% at 520 nm for each culture (Santos, Barros, & Hamdan, 2006) .
Antidermatophytic susceptibility test
Antidermatophytic susceptibility test was performed according to the Clinical Laboratory Standard Institute (CLSI) recommended broth microdilution method for filamentous fungi in RPMI-1640 medium HEPES modification (Sigma Aldrich) supplemented with MOPS buffer (3-morphollinopropane-1-sulfonic acid) (Qualigens Fine Chemicals) (Rex et al., 2008) . Six 96-well plates were used separately i.e. five for lichen extracts and one for sertaconazole. Brief steps involved per plate were as follows: inocula prepared was diluted 1:50 times in testing media i.e. RPMI 1640; test was performed in 96-well flat-bottom microtitre plates; column 1 named as negative control consist of 100 μl RPMI-1640 broth media and 100 μl of inocula prepared and formaldehyde less than 1%; column 2 named as broth control consist of 200 μl of media; columns 3 and 4, 6 and 7, 9 and 10 were vertically diluted with extract having final concentration of 1.25, 0.625, 0.313, 0.156, 0.078, 0.039, 0 .019, and 0.009 mg/ml and named as treated (The final concentration of DMSO is equal to and less than 2.5% which does not interfere the growth of tested pathogens); column 5, 8, and 11 were taken as positive control and contains only 100 μl inocula and 100 μl of RPMI-1640 broth media; column 12 named as extract control and contains vertically diluted extract/drug in the aforementioned concentrations. To encounter the color of extract, optical density (O.D.) of extract control was subtracted from treated columns corresponds to extract treated (Pathak et al., 2015) . Percent inhibition was calculated using following equation:
Minimum Inhibition Concentrations (MICs) were calculated based on optical density recorded with a spectrophotometer (SpectraMax Plus384, Molecular Devices Corporation, USA) at 530 nm after 96 h incubated at 30 ± 2ºC (Table 1) The antifungal activity of lichen acetone extracts was performed along with Sertaconazole Nitrate BP (Glenmark Pharmaceuticals, Nasik, India) as standard chemical. 50 mg ml −1 of stock solution of sertaconazole was prepared and tested at same concentrations as lichen extracts.
MFC was determined by classic method for microbial MBC determination method but with slight modification. 20 μl from treated columns from above MIC wells were transferred into 7 ml tubes of fresh RPMI 1640 medium. Tubes were incubated at 30 ± 2ºC for 4 weeks and checked for the turbidity. Aforementioned procedure was performed with sertaconazole nitrate BP and the concentration at which no turbidity has been achieved was defined as MFC (Veinović et al., 2013) .
Statistical analysis
Independent sample t-test was performed between the control and treated dermatophytes for the measure of Levene's Test for Equality of Variances and t-test for equality of means via SPSS v20.
Conclusion
M. aurulenta exhibited antidermatophytic activity and provides new leads for the exploration of new compounds viz. secalonic acid A and leucotylic acid.
